Otsuka Pharmaceutical Factory, Inc. manufactures and distributes pharmaceutical and nutritional products. Its products include medical foods, hine E-gel, processlead, engelead, innerpower, oronine h ointment, urepearl plus lotion 10 and urepearl plus cream. The company was founded on September 1, 1921 and is headquartered in Naruto, Japan.

Spectrum Solutions LLC engages in product development, custom designing, and manufacturing of containers and packaging solutions primarily for the scientific testing, medical, organic health, and cosmetic sectors. The company was founded by K. Gregg Williams and Bill Phillips in 2005 and is headquartered in Draper, UT.

Terumo is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare.

Maco Pharma designs, manufactures and sells infusion, transfusion and biotherapy systems. The company was founded in 1977 and is headquartered in Tourcoing, France.

Xvivo Perfusion AB is a medical technology company. It involves in developing and marketing solutions and systems for assessing the usability of organs, and maintaining organs in good condition outside the body pending transplantation. Its products include XPS, XPS Disposable Kit, Steen Solution, Organ Chamber, Lung Cannula Set, Perfadex and Silicone Tubing Set. It operates through the Durable Goods and Non-Durable Goods segments. The Durable Goods segment includes sales and rental revenues from machines. The Non-Durable Goods segment covers sales of goods and services that are not durable goods. The company was founded by Magnus Nilsson on December 17, 1998 and is headquartered in Gothenburg, Sweden.

ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.

AboGen is a commercial-stage medical device company that has developed transformative technology: a saliva collection and preservation technology designed to preserve all the components in saliva and potentially replace up to 80% of the 5 billion blood tests performed annually.

Guangzhou Saliai Stemcell Science & Technology Co., Ltd. engages in the provision of stem cell storage, health supplements, biological products, and related health management services. The firm involves in the production of regenerative medicine devices, medical nutrition supplements, and biological & medical cosmetic products. It operates a research and development platform which includes life bank, health management center, medical center, and medical cell center. The company was founded by Hai Jia Chen and Ming Jia Chen on July 7, 2009 and is headquartered in Guangzhou, China.

Brother Industries, Ltd. engages in the manufacture and sale of communication, printing, and electronic products and instruments. It operates through the following segments: Printing and Solutions Business, Personal and Home Business, Machinery Business, Network and Contents Business, Domino Business and Others. The Printing and Solutions Business segment offers printers, all-in-ones, fax machines, and electronic stationeries. The Personal and Home Business segment composes of sewing products, which include home sewing and embroidery machines. The Machinery Business segment supplies industrial sewing machines, garment printers, reducers, gears, and machine tools. The Network and Contents Business segment provides karaoke systems, content-delivery systems, and content services. The Domino Business segment offers coding, marking, and digital printing equipment. The Others segment engages in the sale and leasing of real estate. The company was founded by Kanekichi Yasui in April 1908 and is headquartered in Nagoya, Japan.

BioLife Solutions is located in Bothell, Washington, on a high-tech campus that has its roots as a dairy farm. They design, manufacture, and market proprietary and generic cGMP biopreservation media products for cells, tissues, and organs. They also perform contract research and offer consulting to optimize customer specific biopreservation protocols and processes. And for their direct, distributor, and contract customers, They perform custom formulation, fill, and finish services.

Toray Industries, Inc. (東レ株式会社 Tōre Kabushiki-gaisha) is a multinational corporation headquartered in Japan that specializes in industrial products centered on technologies in organic synthetic chemistry, polymer chemistry, and biochemistry.

From initial concept through to development and production, OPSL’s standard is to provide optimised, advanced organ preservation solutions through specialist knowledge and experience. Our focus is on maintaining the quality and function of the transplant organ in order to improve the outcome of the transplant surgery.

DNA Genotek Inc. provides biological sample collection, stabilization, and preparation products for health research institutes. The company provides human products, such as DNA collection kits, RNA collection kits, stabilization reagents, and preparation reagents; and animal products, which include DNA collection kits and preparation reagents. It also offers mailing accessories, and accessories for assisted collection; and various customization options, such as branding and packaging, barcoding, and French labeling and packaging. The company offers genomic services that include nucleic acid extraction, SNP genotyping, PCR-based assays, whole genome and targeted sequencing, array-based SNP and expression profiling, custom assay development, and bioinformatic analysis, as well as support, analysis, and reporting. DNA Genotek Inc. offers its services in the areas of academic research, clinical diagnostics, micribiome, infectious diseases, biobanking, animal genetics, and HLA typing through sales representatives or service coordinators worldwide. The company was founded in 1998 and is based in Kanata, Canada. As of August 17, 2011, DNA Genotek Inc. operates as a subsidiary of OraSure Technologies, Inc

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

Manufactures and supplies cell biology products

LifeNet Health, Inc. operates as a full-service organ donation agency and tissue banking system. It offers cardiac, vascular, sports medicine, general orthopedics and trauma, craniomaxillofacial, spine, dental, plastic and reconstructive surgical services. The company was founded in 1982 and is headquartered in Virginia Beach, VA.

Bausch & Lomb is a Canadian eye health products company based in Laval, Quebec, Canada. It is one of the world's largest suppliers of contact lenses, lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products. The company was founded in Rochester, New York in 1853 by optician John Bausch and cabinet maker turned financial backer Henry Lomb. Until its sale in 2013, Bausch & Lomb was one of the oldest continually operating companies in the US.

Nanjing Dadi Frozen Food Co., Ltd., established on 2005-05-25, The business scope includes meat products(Smoked sausage and ham products);frozen food[Quick-frozen noodles and rice food(Raw products,Cooked products),Quick-frozen other foods(Quick-frozen meat products,Quick-frozen other products)];Potatoes and puffed food[potato food(other potatoes)]Production,Sales;road freight transport.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

ZENOAQ aims to create a shared and everlasting future for humans and animals. Amidst efforts to improve drug development, veterinary therapy and biotechnology, ZENOAQ strives to enhance the value of animals. The core activities in ZENOAQ are deeply connected with our customers, which in turn, affects their animals in many different ways. These connections form a network that is not just limited to Japan, but is something that will also reach across international borders, creating mutual benefit for both humans and animals in the future.